An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma
ENROLLING
Trial ID:
NCT05605899 Protocol # :
22-467
Phase
III
Disease Sites
Non-Hodgkin's Lymphoma
Principal Investigator
Jacobson, Caron, A
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-467
22-467